Mualliflar

  • F.A Doniyorova
    Tashkent State Dental Institute Tashkent, Uzbekistan

Muallif biografiyasi

  • F.A Doniyorova, Tashkent State Dental Institute Tashkent, Uzbekistan
    Associate Professor, Department of Neurology and Traditional Medicine

DOI:

https://doi.org/10.71337/inlibrary.uz.international-scientific.80241

Kalit so‘zlar:

autism prognostic criteria biomarkers early diagnosis ASD syndromes

Annotasiya

This article explores the prognostic criteria for Autism Spectrum Disorder (ASD) based on a clinical study involving 80 children aged 3 to 7 years. The children were categorized into four subgroups: Kanner's syndrome, Asperger's syndrome, Atypical Autism, and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS). Statistical analysis was used to identify the most significant factors influencing disease prognosis, with data visualized in tables and figures. The study reveals syndrome-specific prognostic features and recommends individualized approaches for diagnosis and intervention.

background image

International scientific journal

“Interpretation and researches”

Volume 1 issue 5 (51) | ISSN: 2181-4163 | Impact Factor: 8.2

133

PROGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER: A

COMPARATIVE ANALYSIS ACROSS SYNDROMES

F.A. Doniyorova

Associate Professor, Department of Neurology and Traditional Medicine Tashkent

State Dental Institute Tashkent, Uzbekistan

Abstract:

This article explores the prognostic criteria for Autism Spectrum

Disorder (ASD) based on a clinical study involving 80 children aged 3 to 7 years.
The children were categorized into four subgroups: Kanner's syndrome, Asperger's
syndrome, Atypical Autism, and Pervasive Developmental Disorder-Not Otherwise
Specified (PDD-NOS). Statistical analysis was used to identify the most significant
factors influencing disease prognosis, with data visualized in tables and figures. The
study reveals syndrome-specific prognostic features and recommends individualized
approaches for diagnosis and intervention.

Keywords:

autism, prognostic criteria, biomarkers, early diagnosis, ASD

syndromes

Introduction

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition

characterized by difficulties in social communication and restricted, repetitive
behaviors. Early diagnosis and prognosis are crucial for developing effective
therapeutic strategies. Recent studies have increasingly focused on identifying
prognostic biomarkers and risk factors that contribute to the trajectory of ASD
development [1, 2]. Autism Spectrum Disorder (ASD) is a multifactorial
neurodevelopmental condition characterized by persistent deficits in social
interaction and communication, as well as restricted, repetitive patterns of behavior,
interests, or activities. The global prevalence of ASD has steadily increased over the
past two decades, now estimated at 1 in 100 children worldwide, with significant
variation across countries and socioeconomic backgrounds (WHO, 2023). This rise
underscores

the

urgent

need

for

early

detection

and

evidence-based

intervention.Although the core features of ASD are well-established, its presentation
is highly heterogeneous, both across and within diagnostic subtypes such as Kanner’s
syndrome (classic autism), Asperger’s syndrome, Atypical Autism, and Pervasive
Developmental Disorder-Not Otherwise Specified (PDD-NOS). These subtypes vary
in terms of language development, cognitive functioning, adaptive behaviors, and
comorbidities, complicating diagnosis and long-term managementRecent advances in
neuroscience and genetics have emphasized the importance of identifying reliable
prognostic criteria that can predict the developmental trajectory and treatment


background image

International scientific journal

“Interpretation and researches”

Volume 1 issue 5 (51) | ISSN: 2181-4163 | Impact Factor: 8.2

134

responsiveness of children with ASD. Prognostic indicators may include a
combination of clinical symptoms, cognitive profiles, biological markers
(biomarkers), neuroimaging findings, and family history. Studies suggest that certain
patterns — such as early language ability, nonverbal IQ, and degree of social
reciprocity — are closely linked with later functional outcomes (Lord et al., 2020;
Vivanti et al., 2022). Therefore, establishing clear prognostic frameworks for children
with different ASD syndromes is essential for personalizing early intervention
strategies, optimizing therapeutic windows, and improving long-term quality of life.
The current study aims to contribute to this goal by analyzing a sample of 80 children
diagnosed with ASD, categorized by syndrome, and assessing key clinical and
developmental variables.

Materials and Methods

This study analyzed clinical data from 80 children aged 3–7 years diagnosed

with ASD, subdivided into four groups: Kanner (n=18), Asperger (n=25), Atypical
(n=17), and PDD-NOS (n=20). Each child was assessed using standardized scales for
language delay, social interaction, repetitive behaviors, cognitive level, and family
history of ASD.

Results

Syndrome

Age

Language

Delay

Social

Interaction

Repetitive

Behavior

Cognitive

Level

Family

History

Asperger

4.38

2.12

3.25

2.75

2.88

0.56

Atypical

4.62

2.62

2.81

2.88

3.31

0.23

Kanner

5.11

2.78

3.61

3.11

2.78

0.50

PDD-

NOS

4.50

2.80

2.50

2.80

3.35

0.45

Table 1 presents the average clinical scores by syndrome type:


background image

International scientific journal

“Interpretation and researches”

Volume 1 issue 5 (51) | ISSN: 2181-4163 | Impact Factor: 8.2

135

Figure 1. Language Delay by Syndrome


Children with Asperger’s syndrome exhibited the least severe language delays

(mean = 2.12), consistent with diagnostic profiles. Kanner’s syndrome and PDD-
NOS presented with moderately higher scores, indicating greater need for early
speech-language intervention.


background image

International scientific journal

“Interpretation and researches”

Volume 1 issue 5 (51) | ISSN: 2181-4163 | Impact Factor: 8.2

136

Figure 2. Social Interaction Difficulties by Syndrome
Interpretation:

Kanner’s group demonstrated the most severe difficulties in social interaction (mean
= 3.61), reflecting core deficits. This contrasts with PDD-NOS (2.50), suggesting a
milder form of social dysfunction.

Figure 3. Repetitive Behavior by Syndrome


Repetitive behaviors were most pronounced in Kanner’s syndrome (mean =

3.11), typical of stereotypic behavior. Atypical cases (2.88) also showed significant
traits, while Asperger and PDD-NOS had less severe expressions.

Figure 4. Cognitive Level by Syndrome


background image

International scientific journal

“Interpretation and researches”

Volume 1 issue 5 (51) | ISSN: 2181-4163 | Impact Factor: 8.2

137

PDD-NOS and Atypical groups exhibited relatively higher cognitive scores

(3.35 and 3.31), associated with more favorable prognosis. In contrast, Kanner’s
group (2.78) indicated lower cognitive capacity, suggesting the need for tailored
educational interventions.

Discussion

Children with Kanner’s syndrome showed the most significant impairments in

social interaction and repetitive behaviors, aligning with earlier findings [3]. In
contrast, children with Asperger’s syndrome showed lower language delays but had
persistent social challenges. These observations support the need for a personalized,
syndrome-specific diagnostic framework [4].

Recent research emphasizes the role of biomarkers in predicting ASD

progression, enhancing early detection [5]. Machine learning models have been
shown to predict ASD with high accuracy using developmental profiles [6].
Moreover, rapid increases in early-life growth markers like head circumference and
weight gain are linked to ASD risk [7].

Conclusion

This study confirms the necessity of a multifaceted approach to assessing

prognostic indicators in ASD. Recognizing syndrome-specific profiles allows for
more targeted interventions and supports early, individualized care strategies.

Recommendations

Utilize biological and behavioral markers for early ASD detection and

prognosis.

Integrate machine learning tools into clinical assessment protocols.
Develop intervention programs tailored to specific ASD syndromes.

References:

1. Frontiers in Neuroscience. (2024). Predictive markers in autism.

https://www.frontiersin.org/articles/10.3389/fnins.2024.1514678

2.

CAS

Insights.

(2024).

Biomarkers

for

autism

diagnosis.

https://www.cas.org/resources/cas-insights/autism-diagnosis-biomarkers

3. Sage Journals. (2023). Prognostic analysis of autism subtypes.

https://journals.sagepub.com/doi/10.1177/02537176231210063

4.

JAMA

Network.

(2024).

AI

for

early

autism

prediction.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822394

5.

PMC.

(2023).

Growth

markers

and

ASD

development.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605556

6.

Autism

Research.

(2023).

Individualized

intervention

in

ASD.

https://onlinelibrary.wiley.com/journal/19393806

7. Neuropsychiatric Disease and Treatment. (2023). Syndrome-specific ASD

features. https://www.dovepress.com/journal/neuropsychiatric-disease-and-treatment

Bibliografik manbalar

Frontiers in Neuroscience. (2024). Predictive markers in autism. https://www.frontiersin.org/articles/10.3389/fnins.2024.1514678

CAS Insights. (2024). Biomarkers for autism diagnosis. https://www.cas.org/resources/cas-insights/autism-diagnosis-biomarkers

Sage Journals. (2023). Prognostic analysis of autism subtypes. https://journals.sagepub.com/doi/10.1177/02537176231210063

JAMA Network. (2024). AI for early autism prediction. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822394

PMC. (2023). Growth markers and ASD development. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605556

Autism Research. (2023). Individualized intervention in ASD. https://onlinelibrary.wiley.com/journal/19393806

Neuropsychiatric Disease and Treatment. (2023). Syndrome-specific ASD features. https://www.dovepress.com/journal/neuropsychiatric-disease-and-treatment